Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
solid tumor
Fierce Biotech
Cell therapy biotech keeps adapting, selling 4 programs for $55M
USWM plans on offering jobs to about half of Adaptimmune’s workforce. As of Dec. 31, 2024, the biotech had 506 employees.
Gabrielle Masson
Jul 28, 2025 10:52am
Astellas wins class-first gastric cancer nod for Vyloy
Oct 18, 2024 3:39pm
AZ, Daiichi's Enhertu cleared by FDA in wide range of tumors
Apr 8, 2024 10:49am
PsiOxus is no more: Meet Akamis Bio
Jan 6, 2023 9:00am
TriSalus inks SPAC merger to fund infusion tech cancer trials
Nov 15, 2022 10:20am
Surge raises $26M to take anti-cancer hydrogel into the clinic
Oct 18, 2022 9:15am
